Global 3D Bio-Printing Market According to Goldstein Research, the global 3D bio-printing market is segmented based on technology and by applications. Application segment is further bifurcated into pharmaceutical, tissue and organ regeneration, bones and 3D cell culture. North America and Europe dominate the global 3D bio-printing market with approximately 60% market share. However, it is expected that Asia Pacific region is poised to take lead in 3D bioprinting technology in future. The Asia Pacific is the key region for the potential adoption of 3D bioprinting technology, dominated by the South Korea, Japan and China, which currently contributes to the 21% of the share in the global 3D bio-printing market. The world is facing the huge shortage of organs available for lifesaving transplants. For instance, in U.K an individual have to wait an average of 944 days for a kidney transplant. There is the similar shortage of liver, lungs and other organs. The shortage of transplant ti...